Clinical trial
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
NCT04062981 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
- Lead sponsor
- SK Life Science, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 3, 2019
- Completion date
- December 14, 2022
- Enrollment
- 15 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.